14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $34.24 $40.91 Wednesday, 24th Apr 2024 COLL stock ended at $35.48. This is 1.28% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 1.95% from a day low at $35.33 to a day high of $36.02.
90 days $31.34 $40.91
52 weeks $20.84 $40.91

Historical Collegium Pharmaceutical prices

Date Open High Low Close Volume
Feb 12, 2024 $33.56 $34.07 $33.56 $33.70 337 418
Feb 09, 2024 $33.36 $33.74 $33.31 $33.48 213 468
Feb 08, 2024 $33.27 $33.35 $32.75 $33.34 356 417
Feb 07, 2024 $33.34 $33.53 $33.06 $33.21 359 588
Feb 06, 2024 $32.99 $33.44 $32.99 $33.24 156 918
Feb 05, 2024 $32.77 $33.33 $32.44 $33.09 210 409
Feb 02, 2024 $33.44 $33.44 $32.74 $32.84 156 777
Feb 01, 2024 $32.98 $33.53 $32.73 $33.47 178 351
Jan 31, 2024 $33.58 $34.24 $32.87 $32.96 264 536
Jan 30, 2024 $33.87 $33.87 $33.07 $33.45 163 051
Jan 29, 2024 $33.10 $33.89 $32.67 $33.89 196 798
Jan 26, 2024 $33.76 $33.76 $33.04 $33.18 177 997
Jan 25, 2024 $33.49 $33.67 $33.09 $33.49 158 464
Jan 24, 2024 $33.15 $33.53 $32.93 $33.14 143 350
Jan 23, 2024 $33.60 $33.84 $32.44 $32.96 267 395
Jan 22, 2024 $33.26 $33.62 $33.05 $33.51 300 763
Jan 19, 2024 $33.04 $33.04 $32.48 $32.99 184 079
Jan 18, 2024 $32.75 $33.75 $32.31 $32.87 224 801
Jan 17, 2024 $32.08 $33.52 $32.04 $32.74 385 557
Jan 16, 2024 $32.49 $32.76 $31.98 $32.35 495 657
Jan 12, 2024 $32.98 $33.00 $32.28 $32.51 245 013
Jan 11, 2024 $32.59 $32.68 $31.95 $32.61 328 335
Jan 10, 2024 $32.28 $32.64 $31.97 $32.63 290 594
Jan 09, 2024 $31.66 $32.45 $31.55 $32.28 334 591
Jan 08, 2024 $32.50 $32.50 $31.37 $31.74 317 060
Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT